Insufficient scRNA-seq data for expression of RNASE3 at single-cell level.
Insufficient scRNA-seq data for expression of RNASE3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 42% | 11.76 | 1104 / 2642 | 65% | 3.64 | 461 / 705 |
spleen | 98% | 263.46 | 235 / 241 | 0% | 0 | 0 / 0 |
lung | 83% | 72.10 | 481 / 578 | 9% | 0.32 | 99 / 1155 |
peripheral blood | 81% | 1518.07 | 756 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 66% | 12.71 | 171 / 258 | 6% | 0.13 | 14 / 230 |
adipose | 42% | 7.79 | 501 / 1204 | 0% | 0 | 0 / 0 |
prostate | 38% | 7.66 | 93 / 245 | 0% | 0.01 | 2 / 502 |
intestine | 33% | 4.89 | 315 / 966 | 5% | 0.08 | 28 / 527 |
skin | 28% | 3.79 | 500 / 1809 | 8% | 0.15 | 40 / 472 |
bladder | 29% | 3.90 | 6 / 21 | 8% | 0.18 | 38 / 504 |
breast | 26% | 3.79 | 119 / 459 | 1% | 0.02 | 16 / 1118 |
blood vessel | 26% | 4.13 | 349 / 1335 | 0% | 0 | 0 / 0 |
kidney | 16% | 2.16 | 14 / 89 | 9% | 0.21 | 85 / 901 |
ovary | 19% | 2.71 | 35 / 180 | 4% | 0.07 | 16 / 430 |
liver | 22% | 6.49 | 50 / 226 | 1% | 0.01 | 3 / 406 |
uterus | 18% | 2.26 | 31 / 170 | 3% | 0.06 | 15 / 459 |
heart | 21% | 3.61 | 180 / 861 | 0% | 0 | 0 / 0 |
pancreas | 9% | 1.17 | 29 / 328 | 10% | 0.19 | 18 / 178 |
stomach | 12% | 1.62 | 43 / 359 | 7% | 0.12 | 19 / 286 |
esophagus | 10% | 1.54 | 149 / 1445 | 4% | 0.07 | 7 / 183 |
thymus | 11% | 1.44 | 70 / 653 | 2% | 0.03 | 10 / 605 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.09 | 3 / 45 |
muscle | 5% | 0.95 | 43 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0002227 | Biological process | innate immune response in mucosa |
GO_0043152 | Biological process | induction of bacterial agglutination |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0006935 | Biological process | chemotaxis |
GO_0045087 | Biological process | innate immune response |
GO_0019731 | Biological process | antibacterial humoral response |
GO_0006401 | Biological process | RNA catabolic process |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0001530 | Molecular function | lipopolysaccharide binding |
GO_0004540 | Molecular function | RNA nuclease activity |
GO_0004519 | Molecular function | endonuclease activity |
GO_0003676 | Molecular function | nucleic acid binding |
Gene name | RNASE3 |
Protein name | Eosinophil cationic protein (ECP) (EC 3.1.27.-) (Ribonuclease 3) (RNase 3) |
Synonyms | ECP RNS3 |
Description | FUNCTION: Cytotoxin and helminthotoxin with low-efficiency ribonuclease activity. Possesses a wide variety of biological activities. Exhibits antibacterial activity, including cytoplasmic membrane depolarization of preferentially Gram-negative, but also Gram-positive strains. Promotes E.coli outer membrane detachment, alteration of the overall cell shape and partial loss of cell content. . |
Accessions | ENST00000304639.4 P12724 |